Tailor made solutions for
drug discovery
Established in 1990 to facilitate interaction between academia and the pharmaceutical industry
We help you build a broad preclinical portfolio for your lead compound
Join industry leaders for a cutting-edge discussion on the latest scientific developments for pulmonary hypertension (PAH)
Contract Research
We offer disease models covering therapeutic areas such as arthritis, cardiovascular disease, diabetes, inflammatory and renal diseases as well as cell-based assays and more.
Consultancy Services
Our expert team of Senior Scientists offer one-to-one discussions and advice on your preclinical testing needs so you get your drug tested in the right model first time.
You may also be interested in:
The Foundation
The William Harvey Research Foundation is a charity promoting and supporting fundamental research into cardiovascular and inflammatory disease, leading to new understanding of the human body, which advances the discovery of new medicines.
The Institute
With more than 500 researchers, William Harvey Research Institute is part of Queen Mary University of London (QMUL) and one of the leading centres in the United Kingdom for pharmacological research, and is now world-renowned as a centre of excellence for cardiovascular and inflammation research.
